PMGC Holdings Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELAB research report →
Companypmgcholdings.com
PMGC Holdings Inc. , a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
- CEO
- Graydon Bensler
- IPO
- 2023
- Employees
- 2
- HQ
- Newport Beach, CA, US
Price Chart
Valuation
- Market Cap
- $3.37M
- P/E
- -0.00
- P/S
- 2.65
- P/B
- 0.00
- EV/EBITDA
- 0.37
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 12.68%
- Op Margin
- -746.57%
- Net Margin
- -873.11%
- ROE
- -116.96%
- ROIC
- -46.26%
Growth & Income
- Revenue
- $590.08K · -76.08%
- Net Income
- $-7,708,137 · -23.41%
- EPS
- $-378.74 · 94.25%
- Op Income
- $-7,376,710
- FCF YoY
- -16.31%
Performance & Tape
- 52W High
- $309.89
- 52W Low
- $1.62
- 50D MA
- $3.49
- 200D MA
- $71.78
- Beta
- -0.28
- Avg Volume
- 7.61M
Get TickerSpark's AI analysis on ELAB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 23 | Parry Jeffrey | other | 0 |
| Sep 30, 22 | Parry Jeffrey | other | 1 |
| Sep 30, 22 | Parry Jeffrey | other | 4 |
| Nov 13, 23 | Daley Juliana | other | 0 |
| Jun 1, 23 | Daley Juliana | other | 4 |
| Mar 6, 25 | Kovalyov George | other | 5 |
| Mar 6, 24 | Kovalyov George | other | 0 |
| Mar 26, 25 | Bensler Graydon | other | 3,036,437 |
| Nov 13, 23 | Bensler Graydon | other | 0 |
| Jan 15, 21 | Bensler Graydon | other | 200,000 |
Our ELAB Coverage
We haven't published any research on ELAB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ELAB Report →